Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 August 1993 | Volume 119 Issue 4 | Pages 304-311
Objective: To determine, through structured methodologic review of published articles, the effectiveness of short-course (
Data Sources: English-language publications on catheter-related S. aureus bacteremia identified using MEDLINE (1966 to the present) and bibliographic review of relevant articles and textbooks.
Study Selection: Any study reporting outcome data for patients with catheter-related S. aureus bacteremia who were treated with short-course therapy.
Data Extraction: Epidemiologic criteria were applied to assess the quality of protection provided by each study against four important types of biases. In addition, the statistical precision of each study was assessed.
Data Synthesis: Eleven studies were identified. Reported late complication rates varied from 0% to 29%; the pooled estimate of the late complication rate was 6.1% (95% CI, 2.0% to 10.2%). Ten of the 11 studies were uncontrolled. Only three provided adequate protection against treatment allocation bias. None of the studies adequately defined the illness under study, and only four provided adequate follow-up. The relapse rates in all 11 studies had low statistical precision. The complication and mortality rates for catheter-related S. aureus bacteremia when published data were pooled, regardless of duration of therapy, were 24% and 15%, respectively.
Conclusions: The available data regarding the safety of short-course therapy for catheter-related S. aureus bacteremia are potentially flawed by both bias and statistical imprecision. The optimal duration of treatment remains unknown. Short-course therapy should be viewed with caution in treating this serious infection until randomized trials determine the comparative rates of late complication.
Author and Article Information
From the University of Virginia, Charlottesville, Virginia.
REVIEW
Short-Course Therapy of Catheter-related Staphylococcus aureus Bacteremia
A Meta-Analysis
2 weeks) antibiotic therapy for catheter-related Staphylococcus aureus bacteremia.
![]()
Requests for Reprints: Barry Farr, MD, MSc, University of Virginia Health Sciences Center, Box 473, Charlottesville, VA 22908.
Acknowledgments: The authors thank Donna Consiglio for technical assistance in preparing this manuscript.
Grant Support: In part by National Institutes of Health training grant T32AI07046.
This article has been cited by other articles:
![]() |
S. J. REHM Staphylococcus aureus: The new adventures of a legendary pathogen Cleveland Clinic Journal of Medicine, March 1, 2008; 75(3): 177 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fortun, F. Grill, P. Martin-Davila, J. Blazquez, M. Tato, J. Sanchez-Corral, L. Garcia-San Miguel, and S. Moreno Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy J. Antimicrob. Chemother., October 1, 2006; 58(4): 816 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Haase, K. A. McCracken, and R. L. Akins Catheter-Related Bloodstream Infections in the Intensive Care Unit Population Journal of Pharmacy Practice, February 1, 2005; 18(1): 42 - 52. [Abstract] [PDF] |
||||
![]() |
V. G. Fowler Jr, M. K. Olsen, G. R. Corey, C. W. Woods, C. H. Cabell, L. B. Reller, A. C. Cheng, T. Dudley, and E. Z. Oddone Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia Arch Intern Med, September 22, 2003; 163(17): 2066 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McGee and M. K. Gould Preventing Complications of Central Venous Catheterization N. Engl. J. Med., March 20, 2003; 348(12): 1123 - 1133. [Full Text] [PDF] |
||||
![]() |
A. K. Gopal, V. G. Fowler Jr, M. Shah, D. Gesty-Palmer, K. A. Marr, R. S. McClelland, L. K. Kong, G. S. Gottlieb, K. Lanclos, J. Li, et al. Prospective Analysis of Staphylococcus aureus Bacteremia in Nonneutropenic Adults With Malignancy J. Clin. Oncol., March 1, 2000; 18(5): 1110 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Jensen, C. H. Wachmann, K. B. Poulsen, F. Espersen, J. Scheibel, P. Skinhoj, and N. Frimodt-Moller Risk Factors for Hospital-Acquired Staphylococcus aureus Bacteremia Arch Intern Med, July 12, 1999; 159(13): 1437 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Rosen, V. G. Fowler Jr., G. R. Corey, S. M. Downs, A. K. Biddle, J. Li, and J. G. Jollis Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia Ann Intern Med, May 18, 1999; 130(10): 810 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Lowy Staphylococcus aureus Infections N. Engl. J. Med., August 20, 1998; 339(8): 520 - 532. [Full Text] [PDF] |
||||
![]() |
S. Harbarth, O. Rutschmann, P. Sudre, and D. Pittet Impact of Methicillin Resistance on the Outcome of Patients With Bacteremia Caused by Staphylococcus aureus Arch Intern Med, January 26, 1998; 158(2): 182 - 189. [Abstract] [Full Text] [PDF] |
||||